BioAge Labs CMO Rubin Paul D buys 5433 shares at $4.11/share on Feb 2.

BioAge Labs, Inc. [BIOA] has announced that Chief Medical Officer Rubin Paul D has engaged in a transaction involving the acquisition of 5433 shares at a price of $4.11 per share on February 2, 2026, as well as the acquisition of an additional 2000 shares at $6.57 per share on the same date. However, it is also noted that Rubin Paul D has sold 7433 shares at a price of $18.75 per share on February 2, 2026.